Samuel Sanchez (BMC Racing) has tested positive for growth hormone releasing peptide GHRP-2, the UCI has announced. The 'adverse analytical finding' is from an out-of-competition test performed on August 9.
GHRP-2 is the same substance that Bardiani-CSF riders Stefano Pirazzi and Nicola Ruffoni tested positive for ahead of the Giro d'Italia. Sanchez was due to ride at the Vuelta a Espana, which starts this Saturday.
"The Union Cycliste Internationale (UCI) announces that Spanish rider Samuel Sánchez Gonzalez was notified of an Adverse Analytical Finding (AAF) of GHRP-2* in a sample collected in the scope of out-of-competition control on 9 August 2017," the UCI wrote in a statement.
ADVERTISEMENT
"The doping control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling. The rider has the right to request and attend the analysis of the B sample.
"In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair."
BMC Racing released a statement soon after the UCI's announcement.
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2iet9Kq
No comments:
Post a Comment